about
Microinvasive squamous cell cervical carcinoma.Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution.Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma.Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy.Gingival metastasis as first sign of multiorgan dissemination of epithelioid malignant mesothelioma.Intestinal type adenocarcinoma of the ethmoid sinus in wood and leather workers: a retrospective study of 153 cases.Malignant degeneration in leiomyomatosis peritonealis disseminata.Immunohistochemical and molecular profile of salivary gland cancer in children.Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell CarcinomaMerkel cell carcinoma of the parotid gland associated with Warthin tumour: report of two casesTP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinusesDocetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancerCetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyHerceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancerPrimary high-grade mucoepidermoid carcinoma of the minor salivary glands with cutaneous metastases at diagnosisAnterior craniofacial resection for malignant paranasal tumors: A monoinstitutional experience of 366 casesCombined sequential approach in locally advanced breast cancerFocus on the breast fascial system: a new approach for inframammary fold reconstructionThyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy?Prognostic factors in microinvasive cervical squamous cell cancer: long-term resultsGenomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
P50
Q35615260-2E6B6ED3-8758-4C49-9575-1651E036D69AQ40452694-A7347B11-D79D-4EF0-8FE9-A28C4329493DQ40485928-7E126837-4D67-4930-972C-495AA7584E60Q43202682-9AF5EE0E-57F4-4A26-8370-B0B519315E0EQ44276680-D64B9ADC-0912-450C-8DA8-F8101334F581Q44323210-98672306-9227-45BB-8287-A73ADC6A18E1Q44480773-FF0BFD9D-8D17-4ACE-A852-0F0003E9232BQ44525947-FD12E061-29BE-403E-B15E-C7E3B41B1B35Q44926116-D0813C9B-90F0-4B41-AF95-1211E3AE17CDQ45366580-4178F2CA-E623-42FA-8396-9B5512B1E24EQ45941733-CC805BF1-2E99-46A5-B8DC-1AE65AB2AB5EQ50476026-78B6C91F-FB50-4328-9EED-BE1DB88A1442Q53054498-796BFEEF-3B14-4111-B808-69F869CBAF52Q53309839-4421DEDC-2926-4067-8ACD-16BA30D9DDECQ53454950-5D9112A7-8D7A-4443-BE6E-FFCCA3A77853Q54129929-0D4E3B09-64D8-435B-9892-1FE9B1EDB719Q54301350-92D09E04-E987-4221-94C6-6C2B10FD25E7Q56532872-88FAC647-4058-429D-9FE2-E13082CDFF61Q57007076-F30ED3DD-285F-4202-8452-A8068619AD4EQ58813410-C10209C8-226A-4C4C-99E0-CD1CA8726EF2Q59647709-5C94DE1A-0EEC-4A95-933F-B72F24CB598AQ60637515-46DD33F7-1BE4-4F19-9A84-D35B00CBC07FQ60637536-BBB28581-1BD0-4B2A-87E7-CE22564FFCC9Q60637551-B42DFC28-A5FF-4B2D-8AB6-B684561D62EEQ62128609-89EA20DE-452B-478F-913F-C0BC08131FA8Q63184914-B1E4DED2-F91F-461F-9516-B7066724C0B5Q77291085-705C22AD-BA1A-4CE2-A7D0-1C705D222007Q80287397-E7D4C7F3-6899-4861-935B-6A3E7066875CQ81318659-963966A9-491C-4B3B-9C7E-71DCEB0FDFC0Q92531835-ADFC0684-96B5-43B2-8425-36024FFF2F1A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pasquale Quattrone
@ast
Pasquale Quattrone
@en
Pasquale Quattrone
@es
Pasquale Quattrone
@nl
Pasquale Quattrone
@sl
type
label
Pasquale Quattrone
@ast
Pasquale Quattrone
@en
Pasquale Quattrone
@es
Pasquale Quattrone
@nl
Pasquale Quattrone
@sl
prefLabel
Pasquale Quattrone
@ast
Pasquale Quattrone
@en
Pasquale Quattrone
@es
Pasquale Quattrone
@nl
Pasquale Quattrone
@sl
P1053
D-7103-2017
P106
P1153
7004000343
P21
P31
P3829
P496
0000-0002-1187-1325
P569
2000-01-01T00:00:00Z